Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

[A multicenter, large-sample, randomized clinical trial on improving the median survival time of advanced non-small cell lung cancer by combination of Ginseng Rg3 and chemotherapy].

  • Authors : Zhang Y; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.; Wang XQ

Subjects: Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*drug therapy

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2018 Apr 23; Vol. 40 (4), pp. 295-299.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].

  • Authors : Liu P; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.; Jiang SY

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/*drug therapy; Age Factors

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2020 Mar 23; Vol. 42 (3), pp. 234-241.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Efficacy of lobaplatin plus S-1 and the predictive value of circulating tumor cell in patients with advanced gastric cancer].

  • Authors : Feng Q; Department of Gastroenterology, Liaocheng People's Hospital, Liaocheng 252000, China.; Zhao JR

Subjects: Neoplastic Cells, Circulating*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Cyclobutanes/Cyclobutanes/Cyclobutanes/*administration & dosage

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2018 Sep 23; Vol. 40 (9), pp. 696-702.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].

  • Authors : Hou Y; Sino-US Center for Lymphoma and Leukemia, Tianjin 300060, China.; Wang HQ

Subjects: Antibodies, Monoclonal, Murine-Derived/Antibodies, Monoclonal, Murine-Derived/Antibodies, Monoclonal, Murine-Derived/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, B-Cell/Lymphoma, B-Cell/Lymphoma, B-Cell/*drug therapy

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2012 Apr; Vol. 34 (4), pp. 306-10.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin/5-Fu-based chemotherapy].

  • Authors : Liang J; Department of Oncology, Affiliated Hospital of Qingdao University Medical College, Qingdao 266003, China. ; Li QF

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; DNA-Binding Proteins/DNA-Binding Proteins/DNA-Binding Proteins/*genetics ; Endonucleases/Endonucleases/Endonucleases/*genetics

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2010 Jul; Vol. 32 (7), pp. 515-9.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Impact of neoadjuvant chemotherapy on the survival of patients with stage IIIc and IV epithelial ovarian cancer].

  • Authors : Yan X; Department of Gynecological Oncology, Peking University School of Oncology, Beijing Cancer Hospital, Beijing Institute for Cancer Research, Beijing 100036, China.; An N

Subjects: Neoadjuvant Therapy*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Cystadenocarcinoma, Papillary/Cystadenocarcinoma, Papillary/Cystadenocarcinoma, Papillary/*drug therapy CP protocol; TP protocol

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2008 Apr; Vol. 30 (4), pp. 298-301.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Clinical analysis of 140 cases of mantle cell lymphoma].

  • Authors : Hu MW; Department of Hematology, Xinhua Hospital of Zhejiang Province, Hangzhou 310014, China.; Lou YJ

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Mantle-Cell/Lymphoma, Mantle-Cell/Lymphoma, Mantle-Cell/*drug therapy; Antibodies, Monoclonal, Murine-Derived/Antibodies, Monoclonal, Murine-Derived/Antibodies, Monoclonal, Murine-Derived/administration & dosage

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2018 May 23; Vol. 40 (5), pp. 390-395.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Clinical analysis of 36 cases of advanced non-small cell lung cancer (NSCLC) with performance status (PS) scores between 2 and 4].

  • Authors : Qin YY; The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory, Guangzhou respiratory health research institute, Guangzhou 510120, China.; Zhang DH

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*drug therapy ; Hypoxia/Hypoxia/Hypoxia/*therapy

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2017 Nov 23; Vol. 39 (11), pp. 855-861.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Efficacy and safety of Xiaoaiping combined with chemotherapy in the treatment of advanced esophageal cancer].

  • Authors : Wang F; Depratement of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.; Fan QX

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Drugs, Chinese Herbal/Drugs, Chinese Herbal/Drugs, Chinese Herbal/*therapeutic use ; Esophageal Neoplasms/Esophageal Neoplasms/Esophageal Neoplasms/*drug therapy

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2017 Jun 23; Vol. 39 (6), pp. 453-457.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma].

  • Authors : Zhang Z; Easterm Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200433.; Wu M

Subjects: Chemoembolization, Therapeutic* ; Hepatectomy*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 1999 May; Vol. 21 (3), pp. 214-6.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  221 results for ""Survival""